Loading...
No images? Click here Confirm subscription7 May 2021 | Issue 21 The science of COVID-19WHO experts explain the science related to COVID-19. This video and audio series is available weekly on WHO's social media channels and on Spotify, Apple Podcasts and other major podcasts platforms. Episode #37 - Treatment and care at home: If you have COVID-19 and are caring for someone or yourself at home, what is the treatment protocol? What is WHO’s guidance on Remdesivir and convalescent plasma therapy? How can you monitor oxygen at home, and when you should call the doctor? Dr Janet Diaz explains. Episode #36 - Safe care at home: If you are caring for yourself or a loved one at home, how can you keep everyone safe? Who should be cared for at home? How do you prevent COVID-19 infection to other family members? Dr April Baller explains. Vaccines explained1. How do vaccines work? AR EN ES FR RU ZH 2. How are vaccines developed? AR EN ES FR RU ZH 3. Manufacturing, safety and quality control of vaccines FR EN ES RU ZH 4. The different types of COVID-19 vaccines AR EN ES FR RU ZH 5. How will there be equitable allocation of limited supplies? AR EN ES FR RU ZH 6. Country readiness for COVID-19 vaccines AR EN ES FR RU ZH 7. The effects of virus variants on COVID-19 vaccines EN NEW: ES FR ZH 8. Safety of COVID-19 Vaccines: EN NEW: ES ZH 9. Getting the COVID-19 Vaccine: EN NEW: ES 10. Side Effects of COVID-19 Vaccines: EN All 'vaccines explained' content AR EN ES FR RU ZH 'Vaccines explained' digital assets - including editable art files ACT-Accelerator one year onThe ACT-Accelerator marked its first anniversary on 23 April 2021 with a special report on the global alliance’s progress against the COVID-19 pandemic. The “ACT Now, ACT Together: 2021 Impact Report” details the major scientific advances that have been made to confront the new disease, along with the history-making collaboration of global health organizations, governments, foundations, civil society, scientists and the private sector. Q&A: What is the ACT-Accelerator? EN NEW: FR ZH COVID-19 storiesCOVID-19 vaccination simulation exercises in Trinidad and Tobago: EN COVAX allocating additional COVID-19 vaccines in the Eastern Mediterranean Region: AR EN Treating COVID-19 in Cox’s Bazar, Bangladesh: EN From arrival to administration at health facilities: COVAX vaccines in Cambodia: EN WHO, Germany launch new global hub for pandemic and epidemic intelligence: EN How COVAX is working to make vaccine equity a reality: EN Vaccine resourcesCOVID-19 vaccine introduction toolkit AR EN ES FR RU ZH The role of community health workers in COVID-19 vaccination: implementation support guide outlines the roles, needs and opportunities for community health workers to contribute to national deployment and vaccination plans. COVID-19 Vaccination Financing and Budgeting Q&A provides a basic introduction into the possible financing and budgeting arrangements around COVID-19 vaccination roll-out. What is the CVIC Tool? video explains the purpose of the COVID-19 Vaccine Introduction and Deployment Costing tool. Disability Considerations for COVID-19 Vaccination aims to ensure equity in access to vaccination against COVID‑19 for persons with disabilities. IASC Frequently Asked Questions: The COVAX Humanitarian Buffer All COVID-19 vaccine information New animationsBreak the chain of COVID-19 transmission Hindi Checkmate COVID-19 EN How different COVID-19 tests work EN COVID-19 course updatesWHO’s online learning platform OpenWHO has reached 5 million course enrolments in 50 languages. All courses are available for free, including 32 courses for COVID-19. NEW: Clinical management of patients with COVID-19: Initial approach to the acutely ill patient OpenWHO has also published COVID-19 courses in national and local languages, recently adding resources in Haitian Creole, Shona, Esperanto and Telugu. The platform also hosts 55 courses on other topics addressing health emergencies and WHO areas of expertise. New photos and video for mediaNew video b-roll COVID-19 vaccinations in Afghanistan and NepalInterview with WHO Representative in IndiaNew photo sets COVID-19 vaccinations in Fiji WHO press briefings on COVID-19 Technical guidanceEstablishment of a COVID-19 mRNA vaccine technology transfer hub to scale up global manufacturing NEW: EN COVID-19 and mandatory vaccination: Ethical considerations and caveats NEW: EN COVID-19 vaccination: supply and logistics guidance: AR EN ES RU NEW: ZH Data for action: achieving high uptake of COVID-19 vaccines EN ES FR RU ZH NEW: AR Evaluation of COVID-19 vaccine effectiveness EN NEW: FR RU Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine: AR EN FR RU ZH NEW: ES Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19 AR EN FR RU ZH NEW: ES Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID19 developed by Oxford University and AstraZeneca AR EN FR RU ZH NEW: ES Priority medical devices list for the COVID-19 response and associated technical specifications EN NEW: AR FR RU ZH Q&A: Food safety: Sale of live wild mammals in traditional food markets EN NEW: AR FR RU ZH Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets EN NEW: AR All COVID-19 technical guidance AR EN ES FR RU ZH More resourcesAll COVID-19 information AR EN ES FR RU ZH Case numbers and vaccination data dashboard and map WHO epidemic information network Download WHO COVID-19 digital contentYou are receiving this email because you subscribed. If you have been forwarded this update you can click here to subscribe.
|
Loading...
Loading...